PHIO PHARMACEUTICALS CORP
PHIO·71880W501·US·Common Stock·Healthcare - Biotechnology-13D/G
PHIO (PHIO PHARMACEUTICALS CORP) is held by 15 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($179,649), JANE STREET GROUP, LLC ($145,410), VANGUARD CAPITAL MANAGEMENT LLC ($97,421). Net institutional sentiment: Bullish.
15
Holders
Avg rating(4 Elite)
$679,226
Total Value
79% (18)
Fund Consensus
11 buying - 3 selling
Who's Trading
InsiderBJBitterman Robert JBuy $10KJun 26, 2026
ActivistCICVI Investments, Inc.9.9%Feb 17, 2026
ActivistMPMitchell P. Kopin9.1%Feb 13, 2026
InsiderBJBitterman Robert JBuy $5KDec 23, 2025
ActivistOAOrca Capital AG4.9%Dec 11, 2025
InsiderBJBitterman Robert JBuy $6KNov 21, 2025
InsiderBJBitterman Robert JBuy $6KNov 18, 2025
InsiderBJBitterman Robert JBuy $2KMay 22, 2025
InsiderBJBitterman Robert JBuy $5KMay 21, 2025
InsiderFLFerrara Robert LBuy $5KMay 20, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer